Department of Pharmacology, Queen's University, Kingston, Canada
Sekine Ozaki is a renowned pharmaceutical researcher and author specializing in the development of novel drug therapies for chronic diseases. With a background in biochemistry and pharmacology, she has spent over 15 years in both academia and the pharmaceutical industry. Dr. Watanabe earned her Ph.D. in Pharmaceutical Sciences from the University of Tokyo, where she also led a research team focusing on the pharmacodynamics of anti-inflammatory drugs.
Opinion Article
Advancing Pharmaceutical Manufacturing: The Transition to Sustainable Practices
Author(s): Sekine Ozaki*